Carolinas Wealth Consulting’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-15
Closed -$2K – 1079
2020
Q3
$2K Buy
+15
New +$1.59K ﹤0.01% 775

Carolinas Wealth Consulting's MYOK Position: Q4 2020 in Review

Carolinas Wealth Consulting sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 15 shares — an estimated $2K sold.

Carolinas Wealth Consulting first reported a position in MYOK in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Carolinas Wealth Consulting reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 15 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2K.
  • Carolinas Wealth Consulting first reported a position in MyoKardia, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Carolinas Wealth Consulting's MyoKardia, Inc. Common Stock position peaked at $2K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Carolinas Wealth Consulting's 13F filing for Q4 2020, filed 16 Feb 2021.